Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
Recruiting
N/A
Interventional Study
Neuromuscular Blockade
Critical Illness
Neurologic Findings
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 19 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Seoul National University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare the effect of use of reversal agents for neuromuscular blockade in critically ill patients on time for neurological assessment after endotracheal intubation
The main questions it aims to answer are:
* The use of reversal agents for neuromuscular blockade after endotracheal intubation may reduce the time for neurological assessment.
* The types of rev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients 19 years of age or older who were intubated after admission to the intensive care unit.
Exclusion Criteria:
* Patients younger than 19 years of age
* Patients who are not neurologically evaluable or have concomitant neurologic dysfunction
* Patients with neuro…
Contacts